sutent
pfizer limited - sunitinibi - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiset aineet - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
thyrogen
sanofi b.v. - tirotropiini alfa - kilpirauhasen vajaatoiminta - anterior aivolisäkkeen etulohkon hormonit ja analogit, aivolisäkkeen ja hypotalamuksen hormonit sekä analogit - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.
ondansetron hexal 2 mg/ml injektioneste, liuos
hexal a/s - ondansetroni hydrochloridum dihydricum - injektioneste, liuos - 2 mg/ml - ondansetroni
sunitinib ratiopharm 12.5 mg kapseli, kova
ratiopharm gmbh - sunitinib - kapseli, kova - 12.5 mg - sunitinibi
sunitinib ratiopharm 25 mg kapseli, kova
ratiopharm gmbh - sunitinib - kapseli, kova - 25 mg - sunitinibi
sunitinib ratiopharm 37.5 mg kapseli, kova
ratiopharm gmbh - sunitinib - kapseli, kova - 37.5 mg - sunitinibi
sunitinib ratiopharm 50 mg kapseli, kova
ratiopharm gmbh - sunitinib - kapseli, kova - 50 mg - sunitinibi
sunitinib sandoz 12.5 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 12.5 mg - sunitinibi
sunitinib sandoz 25 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 25 mg - sunitinibi
sunitinib sandoz 37.5 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 37.5 mg - sunitinibi